PAK7 Antibody Blocking Peptide
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-77237PEP
Key Product Details
Source
Synthetic
Conjugate
Unconjugated
Applications
Antibody Competition
Product Specifications
Description
A blocking peptide containing 13 amino acids near the center of human PAK5.
Source: Synthetic
(Accession #: Q9P286)
Application Notes
This peptide is useful as a blocking peptide for NBP1-77237. For further blocking peptide related protocol, click here.
Protein / Peptide Type
Antibody Blocking Peptide
Formulation, Preparation and Storage
NBP1-77237PEP
| Formulation | PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. |
| Preservative | 0.02% Sodium Azide |
| Concentration | 0.2 mg/ml |
| Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -20C. Avoid freeze-thaw cycles. |
Background: PAK7
PAK (p21-activated kinases) are a family of serine/threonine kinases within the STE ser/thr protein kinase superfamily that play roles in various oncogenic signaling pathways. Cytoskeletal remodeling, motility, proliferation, and aberrant response to apoptosis and mitosis signals are among oncogenic cell functions coordinated by PAK family members. Group I (PAK1, PAK2 and PAK3, also called alpha, gamma and beta, respectively) contain auto-inhibitory and SH3 domains, in addition to the p21-binding and kinase domains present in Group II (PAK4, PAK6 and PAK7).
Long Name
p21/Cdc42/Rac1-activated Kinase 7
Alternate Names
PAK5
Gene Symbol
PAK5
Additional PAK7 Products
Product Documents for PAK7 Antibody Blocking Peptide
Product Specific Notices for PAK7 Antibody Blocking Peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...